Clinical Trials in Denver

Showing 6801-6820 of 18,161 trials

A Study of Repotrectinib in Combination With Other Anticancer Therapies for the Treatment of Subjects With KRAS-Mutant Solid Tumors

NCT05071183

A Phase 1b/2 Study of Repotrectinib in Combination with Other Anticancer Therapies for the Treatment of Subjects with KRAS-Mutant Advanced Solid Tumors (TRIDENT-2)

KRAS Mutation-Related TumorsMetastatic Solid TumorAdvanced Solid Tumor

Turning Point Therapeutics, Inc.9 participantsStarted Sep 2021

California City, California, United States • California City, California, United States • Denver, Colorado, United States +3 more locations

UNKNOWN< 1 mile

PREDICT Trial: PRospective Evaluation of NTM Disease In CysTic Fibrosis

NCT02073409

Isolation of nontuberculous mycobacteria (NTM) from the sputum of individuals with CF is an increasingly common finding, and the lack of an evidenced-based approach to the diagnosis of NTM disease has been identified as one of the greatest unmet needs within the CF community. Current evidence predicts that the prevalence of NTM will remain relatively high in the CF population. Approaches to NTM disease diagnosis differ widely between centers. This study is observational and follows current best practices. The study will help standardize the diagnosis and collect relevant data associated with the diagnosis of NTM disease to build a framework for future therapeutic trials.

Cystic Fibrosis

National Jewish Health200 participantsStarted Dec 2013

Birmingham, Alabama, United States • Los Angeles, California, United States • San Diego, California, United States +16 more locations

A Study of Repotrectinib in Combination With Other Anticancer Therapies for the Treatment of Subjects With KRAS-Mutant Solid Tumors

PREDICT Trial: PRospective Evaluation of NTM Disease In CysTic Fibrosis

Find Trials by Condition in Denver

Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)

Effects of Augmented Renal Clearance on Pharmacokinetic and Pharmacodynamic Properties of Levetiracetam in Subarachnoid Hemorrhage

Longitudinal Innate Immunity and Aging Study

Improving Function in Older Veterans With Hospital-Associated Deconditioning

A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE)

A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)

Multiple Cardiac Sensors for the Management of Heart Failure

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)

Critical Illness Myopathy and Trajectory of Recovery in AKI Requiring CRRT

Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors

Efficacy and Safety of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 Inflammation

Study of Magrolimab (Hu5F9-G4) in Combination With Avelumab in Solid Tumor Participants and Checkpoint-Inhibitor-Naive Ovarian Cancer Participants Who Progress Within 6 Months of Prior Platinum Chemotherapy

Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPA

A Study to Compare the Efficacy and Safety of Lisocabtagene Maraleucel vs Investigator's Choice Options in Adult Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Whose Disease Has Failed Treatment With Both BTKi and BCL2i Therapies

Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures

Effect of CREON on Exocrine Pancreatic Insufficiency (EPI) Symptoms

REDAPT Retrospective-Prospective Modular Stem Study

Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients